William Radvak
Chief Executive Officer bij MONITOR VENTURES INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Mr. William J.
Radvak is an Executive Chairman at NervGen Pharma Corp.
and a President, Chief Executive Officer & Director at Monitor Ventures, Inc. He is on the Board of Directors at Monitor Ventures, Inc. Mr. Radvak was previously employed as an Independent Director by Harrys Manufacturing, Inc., a Chairman & Chief Executive Officer by Silvio Ventures, Inc., a President, Chief Executive Officer & Director by Regency Gold Corp., and a President & Chief Executive Officer by Response Biomedical Corp.
He received his undergraduate degree from the University of British Columbia.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NERVGEN PHARMA CORP.
2.37% | 28-03-2024 | 1 407 500 ( 2.37% ) | 2 M $ | 31-03-2024 |
Actieve functies van William Radvak
Bedrijven | Functie | Begin |
---|---|---|
MONITOR VENTURES INC. | Chief Executive Officer | 22-01-2010 |
NERVGEN PHARMA CORP. | Founder | 19-01-2017 |
Eerdere bekende functies van William Radvak
Bedrijven | Functie | Einde |
---|---|---|
CLEAN AIR METALS INC. | Chief Executive Officer | 29-04-2019 |
HARRYS MANUFACTURING INC. | Director/Board Member | 08-02-2019 |
Silvio Ventures, Inc. | Chairman | 18-07-2008 |
RESPONSE BIOMEDICAL CORP | Chief Executive Officer | - |
Opleiding van William Radvak
University of British Columbia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
MONITOR VENTURES INC. | Non-Energy Minerals |
CLEAN AIR METALS INC. | Non-Energy Minerals |
HARRYS MANUFACTURING INC. | Consumer Non-Durables |
NERVGEN PHARMA CORP. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Response Biomedical Corp.
Response Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies. The firm serves the medical central-lab testing, point of care testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded on August 20, 1980 and is headquartered in Vancouver, Canada. | Commercial Services |
Silvio Ventures, Inc. | Finance |